Loss of CD28 Expression by Liver-Infiltrating T Cells Contributes to Pathogenesis of Primary Sclerosing Cholangitis

Evaggelia Liaskou(Cancer Research UK Clinical Trials Unit), Gideon M. Hirschfield(University Health Network)

Gastroenterology

April 12, 2014

10.1053/j.gastro.2014.04.003

Cited by 105

Related Papers

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

|New England Journal of Medicine|2016|1.1k

Targeting C-reactive protein for the treatment of cardiovascular disease

|Nature|2006|676

Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

|Gastroenterology|2014|563

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

|Nature Genetics|2013|398

The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis

|Hepatology|2015|348